(Q34995139)

English

Defining the scope of evidence-based practice for low-molecular-weight heparin therapy in high-risk patients with unstable angina and non-ST-elevation myocardial infarction.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12428815%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

1 reference

Europe PubMed Central

Defining the scope of evidence-based practice for low-molecular-weight heparin therapy in high-risk patients with unstable angina and non-ST-elevation myocardial infarction (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12428815%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

myocardial infarction

1 reference

based on heuristic

inferred from title

unstable angina

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

James J. Ferguson

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6654075&resulttype=core&format=json

15 May 2020

publication date

1 November 2002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12428815%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Clinical Cardiology

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6654075&resulttype=core&format=json

15 May 2020

25

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6654075&resulttype=core&format=json

15 May 2020

Suppl 1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6654075&resulttype=core&format=json

15 May 2020

16-22

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6654075&resulttype=core&format=json

15 May 2020

Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960251305

7 January 2021

based on heuristic

inferred from DOI database lookup

Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960251305

7 January 2021

based on heuristic

inferred from DOI database lookup

Aspirin, heparin, or both to treat acute unstable angina

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960251305

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960251305

7 January 2021

based on heuristic

inferred from DOI database lookup

Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960251305

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC)

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960251305

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction: FRAX.I.S. (FRAxiparine in

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960251305

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960251305

7 January 2021

based on heuristic

inferred from DOI database lookup

Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960251305

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960251305

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination therapy with tirofiban and enoxaparin in acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960251305

7 January 2021

based on heuristic

inferred from DOI database lookup

Low molecular weight heparin in acute coronary syndrome: evidence for superior or equivalent efficacy compared with unfractionated heparin?

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960251305

7 January 2021

based on heuristic

inferred from DOI database lookup

Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960251305

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960251305

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960251305

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960251305

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960251305

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960251305

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the effects of two doses of recombinant hirudin compared with heparin in patients with acute myocardial ischemia without ST elevation: a pilot study. Organization to Assess Strategies for Ischemic Syndromes (OASIS) Investigators

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960251305

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960251305

7 January 2021

based on heuristic

inferred from DOI database lookup

A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960251305

7 January 2021

based on heuristic

inferred from DOI database lookup

Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960251305

7 January 2021

based on heuristic

inferred from DOI database lookup

Low molecular weight heparin in prevention of restenosis after angioplasty. Results of Enoxaparin Restenosis (ERA) Trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960251305

7 January 2021

based on heuristic

inferred from DOI database lookup

Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty. Results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial). Reduction of Restenosis After PTCA, E

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960251305

7 January 2021

based on heuristic

inferred from DOI database lookup

Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960251305

7 January 2021

based on heuristic

inferred from DOI database lookup

Percutaneous coronary intervention after subcutaneous enoxaparin pretreatment in patients with unstable angina pectoris

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960251305

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CLC.4960251305

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6654075&resulttype=core&format=json

15 May 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6654075&resulttype=core&format=json

15 May 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12428815%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34995139&oldid=1585767764"